Search results for

Levi Bliss proposed to his girlfriend Allison Barron near a hill in Nevada. Then her dad stood on top of the nearby hill with a sign: "Say no." It was a joke, though. She said yes.

Tulsa fell 16 spots to 60th in the Trust for Public Lands’ fifth-annual city park rankings.The ParkScore index grew from America’s 75 largest cities to…

Eight of the world's 10 worst airports were in China, according to a new report by FlightStats.

Industry experts believe the U.S. may be the world’s top crude oil producer this year, a possible boon for Oklahoma’s energy-reliant economy.A forecast…

Singer and songwriter Dion says that his latest project was inspired by a visit to Fresh Air. The acoustic CD, Bronx in Blue, has Dion exploring the blues music he heard during his youth.

For the past 20 years, president and director Gary Graffman has nurtured top talent at Philadelphia's Curtis Institute of Music. Now 77, he's stepping down from his adminstrative posts and focusing once again on teaching piano.

Prime Minister Nouri al-Maliki calls for an Iraqi committee to meet with the U.S. military to establish ground rules for raids on Iraqi homes. He said Iraq "totally rejects" conduct such as the reported killing of 24 Iraqi civilians by U.S. Marines last fall in Haditha.

John Kerry's smile and the Bush-Cheney campaign's fearful rhetoric are among the latest targets for two of America's top political cartoonists. Mike Peters and Mike Luckovich talk with NPR's Renee Montagne about the 2004 presidential campaign.

In his first one-on-one interview with the media since the start of the war in Iraq, Sec. of State Colin Powell talks about expanding the "coalition of the willing" -- and says he has no intentions of stepping down as the nation's top diplomat.

The Pfizer drug company agrees to pay a $430 million fine and plead guilty to illegal marketing practices, U.S. prosecutors say. The unprecedented fine comes after the company admitted that its Warner-Lambert unit promoted Neurontin, an epilepsy drug, for several unapproved uses. The drug remains a top seller for Pfizer, with 2003 sales of $2.7 billion. NPR's Snigdha Prakash reports.